Hong Kong's Rock-One Forms Medical Device JV with BioLight of Israel

Rock-One International of Hong Kong partnered with BioLight Life Sciences, an Israeli medical device company, to commercialize BioLight devices for ophthalmology and oncology in China. As part of the deal, Rock-One invested $6.2 million in BioLight, buying a 19% stake in the company, paying a 12% premium to the 30-day average closing price. In addition, the two companies will form a manufacturing JV, which will be financially supported entirely by Rock-One, to make BioLight devices in China for the China market. More details.... Stock Symbols: (TASE: BOLT; OTC: BLGTY) Share this with colleagues: // //